1DFG
X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND BENZO-DIAZABORINE
1DFG の概要
エントリーDOI | 10.2210/pdb1dfg/pdb |
分子名称 | ENOYL ACYL CARRIER PROTEIN REDUCTASE, NICOTINAMIDE-ADENINE-DINUCLEOTIDE, 2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL (3 entities in total) |
機能のキーワード | oxidoreductase, lipid biosynthesis, diazaborine |
由来する生物種 | Escherichia coli |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 57450.59 |
構造登録者 | |
主引用文献 | Baldock, C.,Rafferty, J.B.,Sedelnikova, S.E.,Baker, P.J.,Stuitje, A.R.,Slabas, A.R.,Hawkes, T.R.,Rice, D.W. A mechanism of drug action revealed by structural studies of enoyl reductase. Science, 274:2107-2110, 1996 Cited by PubMed Abstract: Enoyl reductase (ENR), an enzyme involved in fatty acid biosynthesis, is the target for antibacterial diazaborines and the front-line antituberculosis drug isoniazid. Analysis of the structures of complexes of Escherichia coli ENR with nicotinamide adenine dinucleotide and either thienodiazaborine or benzodiazaborine revealed the formation of a covalent bond between the 2' hydroxyl of the nicotinamide ribose and a boron atom in the drugs to generate a tight, noncovalently bound bisubstrate analog. This analysis has implications for the structure-based design of inhibitors of ENR, and similarities to other oxidoreductases suggest that mimicking this molecular linkage may have generic applications in other areas of medicinal chemistry. PubMed: 8953047DOI: 10.1126/science.274.5295.2107 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.5 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
